"L’hôpital universitaire Avicenne est un hôpital de l’AP-HP situé à Bobigny, Seine-Saint-Denis. Il exerce une triple mission de soins, d’enseignement et de recherche. Il offre une prise en charge experte dans toutes les grandes spécialités médicales et chirurgicales, notamment dans le domaine du cancer et de l’obésité. Avec un centre expert Thorax, une filière gériatrique très complète, le centre d’excellence européen de l’HTA, l’approche innovante du traitement de la pathologie inflammatoire et des maladies infectieuses & tropicales, l’hôpital Avicenne relève les défis de la médecine de demain. Il dispose d’un plateau médico-technique performant, de blocs opératoires ouverts en 2015, d’un TEP Scan et une IRM de dernière génération."

During the past decade, Hôpital Avicenne Hématologie Clinique conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Avicenne Hématologie Clinique" #1 collaborator was "The Leukemia and Lymphoma Society" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Avicenne Hématologie Clinique" are "Acute Myeloid Leukemia" (2 trials), "Acute Myelogenous Leukemia" (1 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "MDS" (1 trials) and "Myelodysplastic Syndrome" (1 trials). Many other conditions were trialed in "Hôpital Avicenne Hématologie Clinique" in a lesser frequency.

Most popular intervention types in "Hôpital Avicenne Hématologie Clinique" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (2 trials), "CPI-613 + High Dose Cytarabine and Mitoxantrone" (1 trials), "Cytarabine" (1 trials), "FT-2102 (olutasidenib)" (1 trials) and "Fludarabine, Cytarabine, Filgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Avicenne Hématologie Clinique" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Avicenne Hématologie Clinique". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hôpital Avicenne Hématologie Clinique, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Avicenne Hématologie Clinique, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".